giiant pharma inc.
Biotechnology ResearchView the employees at
giiant pharma inc.-
Patrick Colin President, Patrick Colin Consultant Inc.
-
Rising Star
Christophe Mellon Chief Executive Officer at giiant-
Lévis, Quebec, Canada
-
Top 5%
-
Overview
Giiant is a preclinical-stage biotech company, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in gastroenterology. Its lead program GT-2108 is a microbiota-activated PDE4 inhibitor prodrugs, with improved drug tolerability and enhanced therapeutic effect.